This application is a competitive renewal of the present Multidisciplinary Training Program in Lung Disease (HL07749), which has been continuously funded since 1993. The goal of the program is produce outstanding biomedical scientists who investigate the manifestations, mechanisms, prevention, and treatment of pulmonary disorders. The program proposes to support 12 postdoctoral fellows (M.D., Ph.D., and M.D./PhD.) per year. The investigative approaches available to trainees include disciplines applicable at the molecular, cellular, tissue, organ, whole animal and clinical population levels. The program is truly multidisciplinary, utilizing faculty trainers from the Medical School, School of Public Health, the College of Pharmacy, and the College of Engineering at the University of Michigan. A close relationship between a primary mentor and a co-mentor(s) with the trainee is the foundation of the training experience. This research experience is supplemented by a core group of lectures, workshops, core conferences, and training in responsible research conduct, career planning, communication skills, and grant writing. Emphasis is placed on personal instruction specifically designed for individual trainees. Faculty and core lectures have been added to further solidify the disciplines of bioinformatics, genetics/epigenetics, metabolomics, and the microbiome. Emerging areas of growth include host- microbe interactions, transplantation biology, regenerative medicine, precision medicine, data science, health services research and multi-institutional disease-specific clinical networks for research. Postdoctoral trainees can acquire Master's Degrees in Clinical Research Design and Statistical Analysis from the School of Public Health or health services research through the National Clinical Scholars Program in Health and Healthcare Research. A broad range of research topics is available to trainees including the pathobiology of acute and chronic lung disease, host defense mechanisms, progenitor cell biology, bioinformatics, long-term outcomes in lung disease and critical illness, physician decision making, cost/benefit analysis, application of medical technology and implementation science. Fellows and mentors are reviewed by a committee that monitors the training and career development of fellows. Eight underrepresented minorities have completed our training program over the past 10 years. Ninety percent of graduates trained in the past 15 years are in academic or industry positions, indicative of the program's success.

Public Health Relevance

The University of Michigan Multidisciplinary Training Program in Lung Disease provides research training for M.D. and Ph.D. scientists in both laboratory-based and clinical studies. The purpose of this training is to produce outstanding biomedical scientists who investigate the manifestations, mechanisms, prevention, and treatment of lung disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Colombini-Hatch, Sandra
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Internal Medicine/Medicine
Schools of Medicine
Ann Arbor
United States
Zip Code
Sheth, Jamie S; Belperio, John A; Fishbein, Michael C et al. (2017) Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease. Chest 151:389-399
Boorsma, Carian E; van der Veen, T Anienke; Putri, Kurnia S S et al. (2017) A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages. Sci Rep 7:12570
Govindan, Sushant; Prescott, Hallie C (2017) Quick Sequential Organ Failure Assessment: Illness Severity Indicator, Clinical Decision Support Tool, or Both? Crit Care Med 45:1947-1949
Roussey, Jonathan A; Viglianti, Steven P; Teitz-Tennenbaum, Seagal et al. (2017) Anti-PD-1 Antibody Treatment Promotes Clearance of Persistent Cryptococcal Lung Infection in Mice. J Immunol 199:3535-3546
Zhou, Xiaofeng; Moore, Bethany B (2017) Lung Section Staining and Microscopy. Bio Protoc 7:
Xu, Jintao; Flaczyk, Adam; Neal, Lori M et al. (2017) Exploitation of Scavenger Receptor, Macrophage Receptor with Collagenous Structure, by Cryptococcus neoformans Promotes Alternative Activation of Pulmonary Lymph Node CD11b+ Conventional Dendritic Cells and Non-Protective Th2 Bias. Front Immunol 8:1231
Neal, Lori M; Xing, Enze; Xu, Jintao et al. (2017) CD4+ T Cells Orchestrate Lethal Immune Pathology despite Fungal Clearance during Cryptococcus neoformans Meningoencephalitis. MBio 8:
Draijer, Christina; Peters-Golden, Marc (2017) Alveolar Macrophages in Allergic Asthma: the Forgotten Cell Awakes. Curr Allergy Asthma Rep 17:12
Fagerlin, Angela; Valley, Thomas S; Scherer, Aaron M et al. (2017) Communicating infectious disease prevalence through graphics: Results from an international survey. Vaccine 35:4041-4047
Sjoding, Michael W; Schoenfeld, David A; Brown, Samuel M et al. (2017) Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints. A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with Acute Respiratory Distress Syndrome. Ann Am Thorac Soc 14:110-117

Showing the most recent 10 out of 274 publications